Med. Pro Praxi 2005; 2: 75-76

Revmatoidní artritida

MUDr. Liliana Šedová
Revmatologický ústav, Praha

Revmatoidní artritida je onemocnění postihující přibližně 1 % populace, častěji ženy (v poměru 2–3:1 oproti mužům). Praktický lékař může očekávat ve své praxi průměrně jeden nový případ každých 12–46 měsíců (1).

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šedová L. Revmatoidní artritida. Med. praxi. 2005;2(2):75-76.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wiles N, Symmons DPM, Harrison B, Barret E, Barret JH et al. Estimating the incidence of rheumatoid arthritis. Artritis Rheum 1999; 42: 1339-46. Go to original source...
    2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324. Go to original source... Go to PubMed...
    3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Artritis Rheum 1994; 37: 481-94. Go to original source... Go to PubMed...
    4. Weinblatt M, Keystone EC, Furst DE et al. Adalimumab a fully human anti-tumor necrosis factor monoclonal antibody, for the treatment of rheumatoid arthritis in patiens taking concomitant MTX. Arthritis Rheum 2003; 48: 35-45. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.